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Key Clinical Message
“Flare-up” reactions are late manifestations of severe T-cell-mediated drug
hypersensitivity reactions. Management is anti-inflammatory treatment and
avoiding unnecessary medicines. Symptoms like fever, lymph node swelling,
and blood count abnormalities may lead to confusion with bacterial infections.
For prompt recognition it is important to keep the differential diagnosis in
mind.
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Introduction
Drug rash with eosinophilia and systemic symptoms
(DRESS), also named drug-induced hypersensitivity syn-
drome (DiHS) is a serious multiorgan disease, which is
caused by a drug-induced specific immune reaction. It is
a delayed-type hypersensitivity reaction mediated by T
cells. Its symptoms include exanthema, fever, most often
eosinophilia, lymphadenopathy, and hepatitis [1]. Occa-
sionally other organs like kidney, heart, lung, pancreas or
bone marrow are affected [1–4]. The drugs most often
involved in these hypersensitivity reactions are anticon-
vulsants, allopurinol, and various antimicrobial drugs
(e.g., sulfonamides, chinolones, minocycline, and anti-
HIV drugs but also beta-lactams). The clinical diagnosis
is difficult because the disease onset is slow, often many
weeks after beginning of therapy, and fever and lym-
phadenopathy suggest an infectious or an autoimmune
disease. Moreover, even after stopping the culprit drug
DRESS symptoms can persist for weeks [5].
Flare-up reactions are late manifestations or more
specifically relapses of drug-induced T-cell-mediated
hypersensitivity reactions, in particular DRESS. The term
“flare-up” reaction was coined for reappearance of clinical
symptoms in severe drug allergies caused by anti-infective
agents which are not due to relapse of the original infec-
tion [6]. However, “flare-up” reactions do not only occur
in drug allergies to anti-infective agents, but also in the
framework of DRESS due to anticonvulsants or other
drugs. Here, we present a case with “flare-up” reactions
during a DRESS (Fig. 1) and present a review of the liter-
ature.
Case
A 64-year-old white women was treated with piperacillin/
tazobactam after perforation of the duodenum pars III as
complication of an endoscopic retrograde cholangiopan-
creatography. 2 days later, she developed fever (T 38.1°C)
with an elevated CRP (451 mg/L). Antibiotics were chan-
ged to meropenem and vancomycin. A CT scan showed a
retroperitoneal abscess. The abscess was drained and gen-
eral condition improved. 24 days after start of merope-
nem and vancomycin, a maculopapular rash appeared on
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the trunk. Over the following days skin eruptions spread
to the limbs and face, associated with axillary and ingu-
inal lymphadenopathy as well as fever (38.8°C). Blood
and urine cultures were taken, but were negative, a chest
radiograph and a CT scan of the abdomen showed no
signs of infection. A serologic search for mycoplasma,
chlamydia trachomatis and hepatitis A, B, C, and D virus
were negative. PCR for CMV, EBV, HHV-6, and HHV-7
showed no viral load at this timepoint. CMV IgG were,
however, positive, IgM negative, indicating that the
patient was already infected at an earlier timepoint.
Antinuclear and anti-neutrophil cytoplasmic antibodies
could not be detected. Antibiotic therapy was changed to
ciprofloxacin and daptomycin. However, in spite of treat-
ment with systemic glucocorticoids (80 mg methylpred-
nisolone per day) the exanthema worsened and even
some bullous skin lesions appeared. Skin biopsy revealed
a perivascular lymphohistiocytic infiltrate with eosinophi-
lic and neutrophilic granulocytes, consistent with drug
hypersensitivity. Based on the skin eruption, presence of
strong eosinophilia (3.01 G/L), elevated liver enzymes,
CRP (72 mg/L), and high fever (39.2°C) a DRESS to
meropenem and vancomycin with flare up on ciprofloxa-
cin and daptomycin was suspected. Antibiotic therapy
was stopped but glucocorticoids continued. After initial
improvement, three additional, short-lived relapses with
worsening exanthema, fever, a rise in CRP and signs of
hepatitis were noticed (Fig. 1): The second “flare-up” was
associated with temporary stopping of corticosteroids.
The third episode occurred 24 h after beginning therapy
with fluconazole and pantoprazole. The forth “flare-up”
reaction was temporally associated with a reactivation of
cytomegalovirus (measured again by PCR, 4866 copies/
mL). Serial blood, urine, and stool cultures were taken
during all flare-up reactions and were all negative. PCR
for EBV, HHV-6, and HHV-7 were measured again at the
fourth flare-up and showed no viral reactivation. A sec-
ond chest radiograph was unremarkable. Over the follow-
ing weeks no new antibiotics were given and
corticosteroids were tapered off. All symptoms disap-
peared (Table 1).
An allergy workup after recovery revealed sensitization
to both initial drugs meropenem and vancomycin in
patch- and lymphocyte transformation testing, but no
sensitization to ciprofloxacin. The patient was treated sev-
eral weeks later with a chinolone and tolerated this medi-
cation well. Several months after the hypersensitivity
reaction, pantozole was reintroduced too without any
problems.
Figure 1. Course of laboratory parameters and body temperature in the described case. Begin of the exanthema on day 1. Presumed trigger of
flare-up reactions (arrows): new introduced ciprofloxacine and daptomycine on day 3 (a), temporary stopp of steroids on day 10 (b), new
introduced fluconazole and pantoprazole on day 17 (c), CMV reactivation measured on the basis of PCR on day 28 (d).
Table 1. Patient characteristics.
Sex, age Female, 64
Causal drug Meropenem
Vancomycin
Confirmed
Time between first drug intake
and manifestation of DRESS
24 days
Clinic Exanthema
Lymphadenopathy
Eosinophilia
Fever
Hepatitis
Number of flares 4
Suspected drug as
trigger for flare
Daptomycine
Ciprofloxacine
Pantoprazole
Fluconazole
Treatment Topical and systemic corticosteroids
Max. Eosinophilia (G/L) 3.01
Viral PCR Positive for CMV (4866 copies/mL),
negative for HHV-6, HHV-7, EBV
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In the suspected first flare-up symptoms worsened on
ciprofloxacine and daptomycine without intermittent
improvement though it was the first exposure for the
patient. This time course suggests an unspecific stimula-
tion and speaks against a T-cell-mediated allergy which
needs usually at least several days to develop. The sus-
pected third relapse developed within 24 h after exposure
to pantoprazole and fluconazole and recovered very soon
after stopping these drugs, which is also not consistent
with a T-cell-mediated allergy. Thus, we have not per-
formed an allergy workup for daptomycine, pantoprazole,
and fluconazole.
Review of the literature
We searched publications on drug rash with eosinophilia
and systemic symptoms (DRESS) in Pub Med and analyzed
articles pertaining to the clinical course of this disease and
“flare-up” reactions. Flare-up reactions are relapses of sev-
ere T-cell-mediated drug hypersensitivity reactions. Only
little is known about the risk to trigger them by exposure to
new introduced drugs. DRESS literature about “flare-up” is
mainly focused on reactivation of human herpes viruses
[7–9]. There are only few data in the literature concerning
the association between secondary administered xenobi-
otics and flare-up reactions in DRESS:
 Voltolini et al. described a case with phenobarbi-
tal-induced DRESS. In the course of DRESS, the
patient was treated with ceftriaxone but developed
a massive flare of symptoms a few days later. A
later evaluation revealed sensitization to both
drugs [10].
 Mennicke et al. published a fatal case of a sul-
fasalacine-induced DRESS. Because of fever and
persistent exanthema, an infection was assumed and
treatment with vancomycin was started. Two days
later, the patient showed an increase in liver
enzymes and rapidly developed a fulminant liver
failure. [11].
 Mardivirin et al. examined 7 DRESS patients, who
had “flare-up” 3–5 days after amoxicillin has been
started. The authors hypothesize that amoxicillin
increases the replication of HHV-6, which facilitates
the development of a flare-up [12]. Indeed, it has
been shown that high doses of penicillin may inhibit
IFNc synthesis in T cells [13].
 There are three more case reports with sulfasalazine
as a DRESS inducing drug. All three patients reacted
with fever, lymphadenopathy, and pharyngitis when
amoxicillin was given [14–16].
 In a study of seven patients who developed a multi-
ple drug hypersensitivity, four patients with DRESS
or severe exanthema developed an additional drug
allergy after introducing a second drug [17].
Our case revisited and discussion
“Flare-up” reactions within the context of DRESS are in
the literature mostly associated with reactivation of
human herpes virus such as HHV-6, HHV-7, EBV, and
CMV. However, this applies only partly to our case:
28 days after appearance of the hypersensitivity reaction,
a CMV reactivation was found as a probable cause of the
fourth flare-up. However, the initial DRESS reaction and
the first three relapses were not associated with detectable
viral activations. In addition, they were also only short
lasting (2–3 days), which would not be expected if they
had been due to herpes virus reactivations. This suggests
that the “flare-ups” were triggered by the newly adminis-
tered drugs.
Generalized drug allergies are accompanied by massive
T-cell activations in the circulating blood – quite similar
to T-cell activations in viral infections [18]. Such T-cell
activations may lower the threshold of T-cell reactivity so
that they can react to binding of drugs to HLA or TCR.
The clinical consequence may be a “flare-up” reaction.
Often this reactivity does not persist after recovery (as in
our case). However, occasionally such reactions may
result in new, additional sensitizations. There may be a
link between “flare-ups” to drugs and multiple drug
hypersensitivity [17].
In our patient the symptoms of lymphadenopathy
and fever 24 days after start of antibiotic therapy
because of retroperitoneal abscess were suggestive for a
relapse of the infection. However, the pattern with
increasing exanthema, eosinophilia, and elevated liver
enzymes led us to the suspected diagnosis of a DRESS.
Serial blood, urine, and stool cultures among other
diagnostic modalities were all negative which supported
the diagnosis of a DRESS. In spite of residual uncer-
tainty, we decided to stop the antibiotic therapy and to
administer systemic glucocorticoid under “waitful watch-
ing”. The further course with improvement and finally
healing and the later allergy workup with demonstration
of fitting sensitizations additionally backed the diagnosis
of a DRESS.
The clinical diagnosis of a DRESS or flare-up in the
acute phase is difficult. Differential diagnoses are infec-
tious or autoimmune disease and there is no reliable
diagnostic test for distinction. As in our case, the pattern
of skin manifestations, blood eosinophilia, organ involve-
ment, time course, and involvement of typical drugs
sometimes may help. Important is to keep the differential
diagnoses in mind.
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Conclusions
In our experience “flare-up” reactions occur mainly in
severe delayed hypersensitivity reactions like DRESS and
severe MPE. They appear hours to days after the adminis-
tration of a new drug, and tend to be interpreted as infec-
tious complication. However, they are probably
attributable to stimulation of preactivated T cells by drugs
binding to TCR and HLA. For the clinician it is impor-
tant to know and consider this phenomenon and to avoid
the use of drugs/xenobiotics, if not urgently needed. The
wide use of antibiotics for prophylaxis or because of
uncertainty [11] as widely used in clinical practice may
do more harm than good during ongoing severe drug
allergy.
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